Anticalcification effects of decellularization, solvent,and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 2, 2012, Pages 383-390

  Lim, Hong Gook ^a   Kim, Soo Hwan ^b   Choi, Sun Young ^b   Kim, Yong Jin ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Bioengineering; Biomaterials; Bioprosthesis; Calcification; Heart valve; Xenograft

Indexed keywords

ALCOHOL; AMINO ACID; CALCIUM; GENIPIN; GLUTARALDEHYDE; IMMUNOGLOBULIN G; OCTANOL; ORGANIC SOLVENT; PHOSPHATE; PRONASE; FIXATIVE; IRIDOID; SOLVENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPROSTHESIS; CELL STRUCTURE; CONTROLLED STUDY; DETOXIFICATION; ENZYME DEGRADATION; MALE; MICROSCOPY; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; ANIMAL; CALCINOSIS; CATTLE; CHEMISTRY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HEAT; MATERIALS TESTING; MECHANICAL STRESS; METHODOLOGY; RABBIT; TISSUE FIXATION; TRANSPLANTATION; XENOGRAFT;

ANIMALS; BIOPROSTHESIS; CALCINOSIS; CALCIUM; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIXATIVES; GLUTARAL; HOT TEMPERATURE; IRIDOIDS; MALE; MATERIALS TESTING; PERICARDIUM; PRONASE; RABBITS; SOLVENTS; STRESS, MECHANICAL; TISSUE FIXATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84860339146     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.05.016     Document Type: Article

References (24)

1. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79: 1072-80.
2. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ. Alpha-GAL on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005;35:17-23.
3. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006; 114:318-27.
4. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-88
5. Jorge-Herrero E, Fernández P, Escudero C, García-Páez JM, Castilo-Olivares JL. Calcification of pericardial tissue pretreated with different amino acids. Biomaterials 1996;17:571-5.
6. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: a biomaterials approach for coronary artery and heart valve replacement. Ann Thorac Surg 1995;60:S353-8.
7. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28: 655-66.
8. Chang Y, Tsai CC, Liang HC, Sung HW. In vivo evaluation of cellular and a ellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002;23:2447-57.
9. Chang Y, Hsu CK, Wei HJ, Chen SC, Liang HC, Lai PH, Sung HW. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: in vitro and in vivo studies. J Biotechnol 2005;120:207-19.
10. Wright GA, Faught JM, Olin JM. Assessing anticalcification treatments in bioprosthetic tissue by using the New Zealand rabbit intramuscular model. Comp Med 2009;59:266-71.
11. Zeeman R, Dijkstra PJ, van Wachem PB, van Luyn MJ, Hendriks M, Cahalan PT, Feijen J. Successive epoxy and carbodiimide cross-linking of dermal sheep collagen. Biomaterials 1999;20:921-31.
12. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002;161:2035-46.
13. Lee C, Kim SH, Choi SH, Kim YJ. High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and postfixation glycine treatment: in vitro material assessment and in vivo anticalcification effect. Eur J Cardiothorac Surg 2011;39:381-7.
14. Grimm M, Grabenwoger M, Eybl E, Moritz A, Bock P, Muller MM, Wolner E. Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment. J Card Surg 1992;7:58-64.
15. Zhou J, Jiang H, Wang D, Hu S. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification. J Heart Valve Dis 2009;18:180-6.
16. Gratzer PF, Pereira CA, Lee JM. Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials. J Biomed Mater Res 1996;31:533-43.
17. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res 2003;66: 93-102.
18. Pathak CP, Adams AK, Simpson T, Phillips RE Jr, Moore MA. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. J Biomed Mater Res 2004;69A:140-4.
19. Samouillan V, Dandurand J, Lacabanne C, Thoma RJ, Adams A, Moore M. Comparison of chemical treatments on the chain dynamics and thermal stability of bovine pericardium collagen. J Biomed Mater Res 2003;64A:330-8.
20. Pettenazzo E, Valente M, Thiene G. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. Eur J Cardiothorac Surg 2008;34: 418-22.
21. Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis 2000;9: 561-6.
22. Schoen FJ. Are immune mechanisms important in tissue heart valve failure? A debate. J Heart Valve Dis 2001;10:458-9.
23. Park SS, Kim WH, Choi SY, Kim YJ. Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A. J Korean Med Sci 2009;24:1126-31.
24. Macher BA, Galili U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008;1780:75-88.